Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
19 hedge funds and large institutions have $612K invested in Yield10 Bioscience, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 7 closing their positions.
323% more capital invested
Capital invested by funds: $145K → $612K (+$468K)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
43% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 7
12% more funds holding
Funds holding: 17 → 19 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$243K |
| 2 |
CS
Cannell & Spears
New York
|
+$65.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$20.6K |
| 4 |
MG
Marex Group
London,
|
+$13.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$5.01K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$9K |
| 2 |
Millennium Management
New York
|
-$7.86K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$6.12K |
| 4 |
Renaissance Technologies
New York
|
-$3K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.42K |
YTEN Hedge Fund Activity: Q1 2024 in Review
19 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2024, worth a combined $612K — up 323% from $145K a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new YTEN positions and 7 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was Armistice Capital, opening a new position worth an estimated $243K. The largest seller was Virtu Financial, exiting entirely with an estimated $9K sold.
- 19 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2024, up from 17 in Q4 2023.
- Funds reported $612K of Yield10 Bioscience, Inc. Common Stock stock for Q1 2024, up 323% quarter-over-quarter.
- 10 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2024 and 7 closed out, a net change of +3 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2024 was Armistice Capital, an estimated $243K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2024 was Virtu Financial, an estimated $9K sold.
Based on aggregated 13F filings for Q1 2024.